BCDA
Biocardia·NASDAQ
--
--(--)
--
--(--)
6.83 / 10
Outperform
Analyst consensus is 100% Strong Buy (one analyst) and sentiment score 6.83 (Outperform). Fund‑flow rating is good (6.73/10) with overall inflow ratio 0.38 but negative trend; small investors are net positive while medium‑large blocks are net negative.
Fund Flow Rating
Analyst RatingStrong Buy
Wall Street Opinions
Strong Buy
Strong Buy
100%
Buy
0%
Hold
0%
Sell
0%
Strong Sell
0%
Date2025-09-22
InstitutionHC Wainwright & Co.
Times predicted1
Historical Win Rate100.0%
What is the analyst consensus for BCDA?
- BCDA holds a Bullish analyst rating, with 100% of experts assigning a Strong Buy grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 6.83/10 (Outperform).
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
